In cervical carcinogenesis, CD49f is assumed as a marker of cervical cancer stem cells potentially linked with CD133 and SOX2 expression [34] and preferentially targeted by high-risk HPVs [22]. This evidence concerns the gene SOX2 and cervical carcinoma.